Fig. 2: Association between PD-L1 TPS and disease outcomes. | Nature Communications

Fig. 2: Association between PD-L1 TPS and disease outcomes.

From: Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC

Fig. 2

a Progression-free (PFS) and b overall survival (OS) by PD-L1 tumor proportion score (TPS) levels ( < 1% vs 1–49% vs 50–89% vs ≥ 90%). c Local-regional and distant control rate at 24-months by PD-L1 TPS levels. P-values are according to log-rank test for (a), (b), and (c). Data are presented as median estimated control rates for (c). CRT chemoradiation. Source data are provided as a Source Data file.

Back to article page